High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial.

Ferreri, A J M

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Aug 2015 - 1760-5 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1569-8041

10.1093/annonc/mdv214 doi


Aged
Aged, 80 and over
Anti-Bacterial Agents--administration & dosage
Breast Neoplasms--drug therapy
Clarithromycin--administration & dosage
Colorectal Neoplasms--drug therapy
Disease-Free Survival
Eye Neoplasms--drug therapy
Female
Humans
Lymphoma, B-Cell, Marginal Zone--drug therapy
Male
Middle Aged
Mouth Neoplasms--drug therapy
Neoplasms, Multiple Primary--drug therapy
Salvage Therapy
Skin Neoplasms--drug therapy
Stomach Neoplasms--drug therapy